Cutting-Edge MedTech: Navigation Sciences CEO on Clear Surgical Margins & Startup Success

Explore how Navigation Sciences streamlines surgical navigation for lung cancer and other tumors, ensuring precise margins through advanced MedTech solutions. Gain insider insights on FDA pathways, fundraising strategies, and the vital collaboration among startups, researchers, and policymakers driving healthcare innovation.

0:00 – Show Introduction & Host Welcome

0:26 – Guest Introduction (Alan Lucas, Navigation Sciences CEO)

1:00 – Overview: Minimally Invasive Surgical Instruments & Implants

2:28 – What Is Navigation Sciences? Soft-Tissue Navigation Explained

4:32 – Surgical Margins & Why Precision Matters

6:02 – Real-Time Navigation: Electromagnetic Sensors & 3D Modeling

8:10 – Future Applications (Head & Neck, Liver, Neurosurgery)

9:22 – Building & Protecting Intellectual Property

10:15 – Funding & Early-Stage Financing Strategy

12:40 – Roadmap to FDA (Feasibility Study & Next Steps)

14:15 – Founders vs. Investors: Finding the Right Partners

15:50 – The New England Executive Network: Connecting MedTech Leaders

18:18 – Wrap-Up & Closing Remarks

Roupen Odabashian:

LinkedIn: https://www.linkedin.com/in/roupen-odabashian-183aaa142/

X: https://twitter.com/RoupenMD

Email: roupen@deltahealth.tech

Watch Our Podcast on Youtube

#MedTech, #HealthTech, #Startup, #HealthcareInnovation, #SurgicalNavigation, #ClearMargins, #LungCancer, #Fundraising, #FDA, #Collaboration, #MinimallyInvasive, #MedicalDevice, #Innovation, #TechTrends, #HealthcareTech